Pictet Asset Management LTD Trimmed Its Emerson Elec Co (EMR) Stake; Profile of 6 Analysts Covering SCYNEXIS, Inc. (SCYX)

February 24, 2018 - By Peter Erickson

Pictet Asset Management Ltd decreased Emerson Elec Co (EMR) stake by 2.03% reported in 2017Q3 SEC filing. Pictet Asset Management Ltd sold 50,032 shares as Emerson Elec Co (EMR)’s stock declined 4.02%. The Pictet Asset Management Ltd holds 2.41 million shares with $151.49M value, down from 2.46 million last quarter. Emerson Elec Co now has $45.83 billion valuation. The stock increased 0.14% or $0.1 during the last trading session, reaching $72.19. About 1.90 million shares traded. Emerson Electric Co. (NYSE:EMR) has risen 18.47% since February 24, 2017 and is uptrending. It has outperformed by 1.77% the S&P500.

Among 7 analysts covering Scynexis Inc (NASDAQ:SCYX), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Scynexis Inc had 13 analyst reports since August 20, 2015 according to SRatingsIntel. The stock has “Outperform” rating by RBC Capital Markets on Monday, November 16. As per Wednesday, August 17, the company rating was initiated by Guggenheim. The company was upgraded on Tuesday, August 9 by WBB Securities. H.C. Wainwright initiated SCYNEXIS, Inc. (NASDAQ:SCYX) on Thursday, October 20 with “Buy” rating. The firm earned “Buy” rating on Monday, October 3 by Brean Capital. The company was maintained on Wednesday, August 9 by Needham. The firm has “Strong Buy” rating by WBB Securities given on Friday, October 7. The firm earned “Buy” rating on Wednesday, August 16 by H.C. Wainwright. The rating was maintained by Roth Capital with “Buy” on Monday, August 7. Brean Capital initiated it with “Buy” rating and $16 target in Monday, March 28 report. See SCYNEXIS, Inc. (NASDAQ:SCYX) latest ratings:

24/10/2017 Broker: Guggenheim Rating: Buy New Target: $6 Initiates Coverage On

SCYNEXIS, Inc., a drug development company, develops and commercializes anti-infectives to address unmet therapeutic needs. The company has market cap of $48.55 million. It is developing its lead product candidate, SCY-078, as a novel oral and intravenous drug for the treatment of various fungal infections, including serious and life-threatening invasive fungal infections. It currently has negative earnings. The firm also develops SCY-078, which is in various Phase I studies for the oral and intravenous formulations, as well as has completed Phase II study as a step-down therapy in patients with invasive candidiasis and vulvovaginal candidiasis.

Investors sentiment increased to 1.09 in Q3 2017. Its up 0.09, from 1 in 2017Q2. It increased, as 5 investors sold SCYNEXIS, Inc. shares while 6 reduced holdings. 4 funds opened positions while 8 raised stakes. 8.55 million shares or 7.29% less from 9.22 million shares in 2017Q2 were reported. California Employees Retirement Systems has 0% invested in SCYNEXIS, Inc. (NASDAQ:SCYX). Rbf Capital Limited Liability accumulated 11,100 shares. Geode Mngmt Limited Liability accumulated 128,724 shares. Federated Pa holds 4.21 million shares. Vanguard Grp accumulated 0% or 832,987 shares. Iguana Mgmt Ltd Liability invested in 250,000 shares or 0.34% of the stock. Retail Bank Of New York Mellon accumulated 19,455 shares. Creative Planning has 47,300 shares. Art Advisors Limited Liability Co stated it has 0.01% of its portfolio in SCYNEXIS, Inc. (NASDAQ:SCYX). Opus Point Prtn Management Ltd Liability has 66,608 shares. Moreover, Virtu Fincl Limited Liability Corporation has 0% invested in SCYNEXIS, Inc. (NASDAQ:SCYX). Private Advisor Group Ltd Liability Corporation accumulated 200,000 shares. Blackrock Incorporated holds 0% or 99,827 shares in its portfolio. Northern Corporation has invested 0% of its portfolio in SCYNEXIS, Inc. (NASDAQ:SCYX). Royal Bank & Trust Of Canada stated it has 7,304 shares.

The stock decreased 0.58% or $0.01 during the last trading session, reaching $1.7. About 49,553 shares traded. SCYNEXIS, Inc. (NASDAQ:SCYX) has declined 46.67% since February 24, 2017 and is downtrending. It has underperformed by 63.37% the S&P500.

Pictet Asset Management Ltd increased Ansys Inc (NASDAQ:ANSS) stake by 130,628 shares to 1.09 million valued at $133.98M in 2017Q3. It also upped Imperva Inc (NYSE:IMPV) stake by 32,383 shares and now owns 388,104 shares. Nvidia Corp (NASDAQ:NVDA) was raised too.

Among 29 analysts covering Emerson Electric Co. (NYSE:EMR), 12 have Buy rating, 2 Sell and 15 Hold. Therefore 41% are positive. Emerson Electric Co. had 86 analyst reports since August 6, 2015 according to SRatingsIntel. Barclays Capital maintained the stock with “Equal-Weight” rating in Monday, October 5 report. The firm has “Hold” rating given on Tuesday, August 1 by Oppenheimer. HSBC upgraded the stock to “Hold” rating in Friday, March 3 report. Cowen & Co maintained Emerson Electric Co. (NYSE:EMR) rating on Thursday, June 22. Cowen & Co has “Hold” rating and $6200 target. The stock of Emerson Electric Co. (NYSE:EMR) has “Market Perform” rating given on Thursday, February 1 by JMP Securities. The stock of Emerson Electric Co. (NYSE:EMR) earned “Hold” rating by RBC Capital Markets on Monday, July 10. As per Tuesday, November 7, the company rating was initiated by Cowen & Co. On Tuesday, August 1 the stock rating was maintained by RBC Capital Markets with “Hold”. The stock of Emerson Electric Co. (NYSE:EMR) earned “Outperform” rating by RBC Capital Markets on Wednesday, February 14. Stifel Nicolaus maintained Emerson Electric Co. (NYSE:EMR) rating on Friday, January 19. Stifel Nicolaus has “Buy” rating and $83.0 target.

Since August 31, 2017, it had 0 insider purchases, and 2 sales for $616,887 activity. $117,987 worth of Emerson Electric Co. (NYSE:EMR) shares were sold by Sharp Robert T. Button Bell Katherine sold $498,900 worth of stock or 7,518 shares.

Investors sentiment decreased to 0.86 in 2017 Q3. Its down 0.14, from 1 in 2017Q2. It worsened, as 44 investors sold EMR shares while 444 reduced holdings. 92 funds opened positions while 328 raised stakes. 432.93 million shares or 1.76% less from 440.67 million shares in 2017Q2 were reported. 3,854 were accumulated by Pettyjohn Wood & White Inc. Hightower Advsrs Llc reported 262,035 shares. St Germain D J invested in 4,665 shares. Security National Bank Of Sioux City Iowa Ia holds 0.95% or 15,398 shares in its portfolio. Montag A Incorporated reported 0.12% stake. Invesco Ltd holds 0.25% or 10.84 million shares in its portfolio. Moreover, Ronna Sue Cohen has 1.05% invested in Emerson Electric Co. (NYSE:EMR) for 21,849 shares. Fayerweather Charles reported 0.49% stake. Parkside State Bank holds 0.15% or 6,080 shares. Fukoku Mutual Life Insurance reported 3,300 shares. 3,300 are owned by Mountain Pacific Inv Advisers Inc Id. Breton Hill Capital Ltd accumulated 31,160 shares. Ramsay Stattman Vela Price reported 81,457 shares. Hilltop Incorporated reported 0.08% of its portfolio in Emerson Electric Co. (NYSE:EMR). Hartford Inv Mngmt has 151,236 shares.

Analysts await Emerson Electric Co. (NYSE:EMR) to report earnings on May, 1. They expect $0.71 earnings per share, up 22.41% or $0.13 from last year’s $0.58 per share. EMR’s profit will be $450.74 million for 25.42 P/E if the $0.71 EPS becomes a reality. After $0.58 actual earnings per share reported by Emerson Electric Co. for the previous quarter, Wall Street now forecasts 22.41% EPS growth.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: